Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication

International Journal of Molecular Sciences - Tập 19 Số 12 - Trang 3742
Yang-Hsiang Lin1,2, Meng‐Han Wu1, Chau‐Ting Yeh2, Kwang‐Huei Lin1,2,3
1Department of Biochemistry, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
2Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan
3Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan

Tóm tắt

The tumor microenvironment is an important concept that defines cancer development not only through tumor cells themselves but also the surrounding cellular and non-cellular components, including stromal cells, blood vessels, infiltrating inflammatory cells, cancer stem cells (CSC), cytokines, and growth factors, which act in concert to promote tumor cell survival and metastasis. Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies worldwide. Poor prognosis is largely attributable to the high rate of tumor metastasis, highlighting the importance of identifying patients at risk in advance and developing novel therapeutic targets to facilitate effective intervention. Long non-coding RNAs (lncRNA) are a class of non-protein coding transcripts longer than 200 nucleotides frequently dysregulated in various cancer types, which have multiple functions in widespread biological processes, including proliferation, apoptosis, metastasis, and metabolism. lncRNAs are involved in regulation of the tumor microenvironment and reciprocal signaling between cancer cells. Targeting of components of the tumor microenvironment or cancer cells has become a considerable focus of therapeutic research and establishing the effects of different lncRNAs on this network should aid in the development of effective treatment strategies. The current review provides a summary of the essential properties and functional roles of known lncRNAs associated with the tumor microenvironment in HCC.

Từ khóa


Tài liệu tham khảo

Balkwill, 2012, The tumor microenvironment at a glance, J. Cell Sci., 125, 5591, 10.1242/jcs.116392

Yuan, 2016, Role of the tumor microenvironment in tumor progression and the clinical applications (Review), Oncol. Rep., 35, 2499, 10.3892/or.2016.4660

Rudolph, 2007, Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061

Artandi, 2010, Telomeres and telomerase in cancer, Carcinogenesis, 31, 9, 10.1093/carcin/bgp268

Uchino, 2011, Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors, Cancer, 117, 4475, 10.1002/cncr.25960

Mehlen, 2006, Metastasis: A question of life or death, Nat. Rev. Cancer, 6, 449, 10.1038/nrc1886

Wang, 2013, The role of noncoding RNA in hepatocellular carcinoma, Gland Surg., 2, 25

Li, 2014, lncRNAs: Insights into their function and mechanics in underlying disorders, Mutat. Res. Rev. Mutat. Res., 762, 1, 10.1016/j.mrrev.2014.04.002

Tsai, 2012, MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, J. Clin. Investing., 122, 2884, 10.1172/JCI63455

Xu, 2013, Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis, J. Clin. Investing., 123, 630

Melo, 2012, Molecular pathways: MicroRNAs as cancer therapeutics, Clin. Cancer Res., 18, 4234, 10.1158/1078-0432.CCR-11-2010

Slack, 2006, Oncomirs-microRNAs with a role in cancer, Nat. Rev. Cancer, 6, 259, 10.1038/nrc1840

He, 2009, MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta, Cell. Mol. Immunol., 6, 343, 10.1038/cmi.2009.45

Yang, 2012, TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma, Cancer Cell, 22, 291, 10.1016/j.ccr.2012.07.023

Chai, 2015, microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma, J. Hematol. Oncol., 8, 56, 10.1186/s13045-015-0150-4

Rinn, 2012, Genome regulation by long noncoding RNAs, Annu. Rev. Biochem., 81, 145, 10.1146/annurev-biochem-051410-092902

Capaccioli, 2014, A pathophysiological view of the long non-coding RNA world, Oncotarget, 5, 10976, 10.18632/oncotarget.2770

Fitzgerald, 2014, Long noncoding RNAs in innate and adaptive immunity, Curr. Opin. Immunol., 26, 140, 10.1016/j.coi.2013.12.001

Atianand, 2014, Long non-coding RNAs and control of gene expression in the immune system, Trends Mol. Med., 20, 623, 10.1016/j.molmed.2014.09.002

Wang, 2011, Molecular mechanisms of long noncoding RNAs, Mol. Cell, 43, 904, 10.1016/j.molcel.2011.08.018

Sado, 2005, Tsix silences Xist through modification of chromatin structure, Dev. Cell, 9, 159, 10.1016/j.devcel.2005.05.015

Tsai, 2010, Long noncoding RNA as modular scaffold of histone modification complexes, Science, 329, 689, 10.1126/science.1192002

Tripathi, 2010, The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, Mol. Cell, 39, 925, 10.1016/j.molcel.2010.08.011

Loewer, 2010, Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells, Nat. Genet., 42, 1113, 10.1038/ng.710

Nelson, 2016, A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle, Science, 351, 271, 10.1126/science.aad4076

Kartha, 2014, Competing endogenous RNAs (ceRNAs): New entrants to the intricacies of gene regulation, Front. Genet., 5, 8, 10.3389/fgene.2014.00008

Sang, 2018, lncRNA CamK-A Regulates Ca(2+)-Signaling-Mediated Tumor Microenvironment Remodeling, Mol. Cell, 72, 601, 10.1016/j.molcel.2018.10.024

Petrova, 2018, The hypoxic tumour microenvironment, Oncogenesis, 7, 10, 10.1038/s41389-017-0011-9

Quail, 2013, Microenvironmental regulation of tumor progression and metastasis, Nat. Med., 19, 1423, 10.1038/nm.3394

Martin, 2016, Targeting microenvironment in cancer therapeutics, Oncotarget, 7, 52575, 10.18632/oncotarget.9824

Lyssiotis, 2017, Metabolic Interactions in the Tumor Microenvironment, Trends Cell Biol., 27, 863, 10.1016/j.tcb.2017.06.003

Erdogan, 2017, Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis, Biochem. Soc. Trans., 45, 229, 10.1042/BST20160387

Xing, 2010, Cancer associated fibroblasts (CAFs) in tumor microenvironment, Front. Biosci., 15, 166, 10.2741/3613

Tao, 2017, Cancer associated fibroblasts: An essential role in the tumor microenvironment, Oncol. Lett., 14, 2611, 10.3892/ol.2017.6497

Lau, 2016, Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling, Cell Rep., 15, 1175, 10.1016/j.celrep.2016.04.019

Liu, 2016, Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-beta pathways, Cancer Lett., 379, 49, 10.1016/j.canlet.2016.05.022

Song, 2015, TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma, Oncotarget, 6, 12061, 10.18632/oncotarget.3616

Cheng, 2016, Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation, Oncogenesis, 5, e198, 10.1038/oncsis.2016.7

Zhao, 2017, Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer, Cancer Res., 77, 1369, 10.1158/0008-5472.CAN-16-1615

Yin, 2013, Hepatic stellate cells in liver development, regeneration, and cancer, J. Clin. Investing., 123, 1902, 10.1172/JCI66369

Seki, 2015, Hepatic inflammation and fibrosis: Functional links and key pathways, Hepatology, 61, 1066, 10.1002/hep.27332

Amann, 2009, Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma, Cancer Sci., 100, 646, 10.1111/j.1349-7006.2009.01087.x

Bian, 2017, Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 674, 10.1016/j.bbadis.2016.12.009

Li, X.Q., Ren, Z.X., Li, K., Huang, J.J., Huang, Z.T., Zhou, T.R., Cao, H.Y., Zhang, F.X., and Tan, B. (2018). Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis. Int. J. Mol. Sci., 19.

Smith, 2013, The metastasis-promoting roles of tumor-associated immune cells, J. Mol. Med., 91, 411, 10.1007/s00109-013-1021-5

Capece, 2013, The inflammatory microenvironment in hepatocellular carcinoma: A pivotal role for tumor-associated macrophages, Biomed. Res. Int., 2013, 187204, 10.1155/2013/187204

Zheng, 2017, Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy, Oncotarget, 8, 48436, 10.18632/oncotarget.17061

Kubo, 2016, Cancer-associated fibroblasts in hepatocellular carcinoma, World J. Gastroenterol., 22, 6841, 10.3748/wjg.v22.i30.6841

Duffy, 2015, The yin and yang of evasion and immune activation in HCC, J. Hepatol., 62, 1420, 10.1016/j.jhep.2015.02.038

Ju, 2016, Hepatic macrophages in homeostasis and liver diseases: From pathogenesis to novel therapeutic strategies, Cell. Mol. Immunol., 13, 316, 10.1038/cmi.2015.104

Huang, 2017, lncRNA-MALAT1 Promotes Angiogenesis of Thyroid Cancer by Modulating Tumor-Associated Macrophage FGF2 Protein Secretion, J. Cell. Biochem., 118, 4821, 10.1002/jcb.26153

Wu, 2018, Long noncoding RNA hypoxia-inducible factor 1 alpha-antisense RNA 1 promotes tumor necrosis factor-alpha-induced apoptosis through caspase 3 in Kupffer cells, Medicine, 97, e9483, 10.1097/MD.0000000000009483

Hida, K., Maishi, N., Annan, D.A., and Hida, Y. (2018). Contribution of Tumor Endothelial Cells in Cancer Progression. Int. J. Mol. Sci., 19.

Benetti, 2008, Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium, Cancer Res., 68, 8626, 10.1158/0008-5472.CAN-08-1218

Xiong, 2009, Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells, Clin. Cancer Res., 15, 4838, 10.1158/1078-0432.CCR-08-2780

Dong, 2016, Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma, Cell Death Dis., 7, e2278, 10.1038/cddis.2016.143

Lu, 2016, Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1), Oncotarget, 7, 241, 10.18632/oncotarget.6280

Yuan, 2012, Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients’ poor recurrence-free survival after hepatectomy, Hepatology, 56, 2231, 10.1002/hep.25895

Zheng, 2018, lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR26b to activate CTGF/ANGPT2, Int. J. Mol. Med., 42, 489

Yu, 2018, Angio-lncRs: lncRNAs that regulate angiogenesis and vascular disease, Theranostics, 8, 3654, 10.7150/thno.26024

Chiba, 2016, Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology, Hepatol. Res., 46, 50, 10.1111/hepr.12548

Xiao, 2017, The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy, Anal. Cell. Pathol., 2017, 5108653, 10.1155/2017/5108653

Ji, 2012, Clinical implications of cancer stem cell biology in hepatocellular carcinoma, Semin. Oncol., 39, 461, 10.1053/j.seminoncol.2012.05.011

Cai, 2014, HOTAIR: A cancer-related long non-coding RNA, Neoplasma, 61, 379, 10.4149/neo_2014_075

Wang, 2015, The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling, Cell Stem Cell, 16, 413, 10.1016/j.stem.2015.03.003

Ding, L.J., Li, Y., Wang, S.D., Wang, X.S., Fang, F., Wang, W.Y., Lv, P., Zhao, D.H., Wei, F., and Qi, L. (2016). Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1. Int. J. Mol. Sci., 17.

Wang, 2014, Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2, Hepatology, 60, 1278, 10.1002/hep.27239

Conigliaro, 2015, CD90+ liver Cancer Cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA, Mol. Cancer, 14, 155, 10.1186/s12943-015-0426-x

Zhu, 2016, lncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells, Nat. Commun., 7, 13608, 10.1038/ncomms13608

Chen, 2016, lncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression, Nat. Commun., 7, 12598, 10.1038/ncomms12598

Wang, 2015, Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway, Oncotarget, 6, 7899, 10.18632/oncotarget.3219

Gui, 2015, Long Noncoding RNA CUDR Regulates HULC and beta-Catenin to Govern Human Liver Stem Cell Malignant Differentiation, Mol. Ther., 23, 1843, 10.1038/mt.2015.166

Pu, 2015, CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc, Oncotarget, 6, 40775, 10.18632/oncotarget.5805

Masoud, 2015, HIF-1alpha pathway: Role, regulation and intervention for cancer therapy, Acta Pharm. Sin. B, 5, 378, 10.1016/j.apsb.2015.05.007

Luo, 2014, The role of hypoxia inducible factor-1 in hepatocellular carcinoma, Biomed. Res. Int., 2014, 409272, 10.1155/2014/409272

Palazon, 2014, HIF transcription factors, inflammation, and immunity, Immunity, 41, 518, 10.1016/j.immuni.2014.09.008

Zheng, 2018, HIF-2alpha activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial-mesenchymal transition, J. Cell. Biochem., 119, 3247, 10.1002/jcb.26481

Luo, 2016, A MALAT1/HIF-2alpha feedback loop contributes to arsenite carcinogenesis, Oncotarget, 7, 5769, 10.18632/oncotarget.6806

Wang, 2016, Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1alpha activity and inhibiting epithelial-mesenchymal transition, Oncotarget, 7, 43588, 10.18632/oncotarget.9635

Wang, 2017, Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1alpha inactivation, Oncotarget, 8, 82280, 10.18632/oncotarget.19316

Yang, 2013, Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis, Mol. Cell, 49, 1083, 10.1016/j.molcel.2013.01.010

Budhu, 2006, The role of cytokines in hepatocellular carcinoma, J. Leukoc. Biol., 80, 1197, 10.1189/jlb.0506297

Yu, 2018, Role of nonresolving inflammation in hepatocellular carcinoma development and progression, NPJ Precis. Oncol., 2, 6, 10.1038/s41698-018-0048-z

Rider, 2016, Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations, Int. J. Cell Biol., 2016, 9259646, 10.1155/2016/9259646

Toffanin, 2013, Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma, Gastroenterology, 144, 512, 10.1053/j.gastro.2013.01.002

Capone, 2016, Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays, Med. Inflamm., 2016, 3064643, 10.1155/2016/3064643

Peng, 2017, Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8, Sci. Rep., 7, 4186, 10.1038/s41598-017-04045-5

Ding, 2018, Long noncoding RNA PVT1 inhibits interferon-alpha mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1, Biochem. Biophys. Res. Commun., 500, 973, 10.1016/j.bbrc.2018.04.219

Li, 2017, The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation, J. Exp. Clin. Cancer Res., 36, 51, 10.1186/s13046-017-0519-z

Lin, 2018, Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1alpha/VEGFA signalling in hepatocellular carcinoma, J. Exp. Clin. Cancer Res., 37, 113, 10.1186/s13046-018-0727-1

Zhang, 2018, Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway, Hepatology, 67, 171, 10.1002/hep.29405

Marquardt, 2018, The Role of Transforming Growth Factor-beta in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications From an Integrative Multiomics Approach, Gastroenterology, 154, 17, 10.1053/j.gastro.2017.11.015

Fabregat, 2018, Transforming Growth Factor-beta-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis, Front. Oncol., 8, 357, 10.3389/fonc.2018.00357

Neuzillet, 2015, Targeting the TGFbeta pathway for cancer therapy, Pharmacol. Ther., 147, 22, 10.1016/j.pharmthera.2014.11.001

Wang, 2010, TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3, Oncogene, 29, 1787, 10.1038/onc.2009.468

Huang, 2008, Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells, Int. J. Cancer, 123, 972, 10.1002/ijc.23580

Merdrignac, 2018, A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma, Hepatol. Commun., 2, 254, 10.1002/hep4.1142

Yuan, 2014, A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma, Cancer Cell, 25, 666, 10.1016/j.ccr.2014.03.010

He, 2015, Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs, Carcinogenesis, 36, 1008, 10.1093/carcin/bgv081

Sun, 2018, Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment, Mol. Cancer, 17, 82, 10.1186/s12943-018-0831-z

Hu, 2018, Exosome-related tumor microenvironment, J. Cancer, 9, 3084, 10.7150/jca.26422

Li, 2018, exoRBase: A database of circRNA, lncRNA and mRNA in human blood exosomes, Nucleic Acids Res., 46, D106, 10.1093/nar/gkx891

Kogure, 2013, Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer, Genes Cancer, 4, 261, 10.1177/1947601913499020

Takahashi, 2014, Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy, Mol. Cancer Res., 12, 1377, 10.1158/1541-7786.MCR-13-0636

Takahashi, 2014, Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer, FEBS Open Bio, 4, 458, 10.1016/j.fob.2014.04.007

Sun, 2018, Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma, J. Cancer, 9, 2631, 10.7150/jca.24978

Zhang, 2018, lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma, Cancer Biomark., 21, 651, 10.3233/CBM-170727

Frantz, 2010, The extracellular matrix at a glance, J. Cell Sci., 123, 4195, 10.1242/jcs.023820

Noel, 2012, New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment, Front. Pharmacol., 3, 140, 10.3389/fphar.2012.00140

2012, Matrix metalloproteinases: Changing roles in tumor progression and metastasis, Am. J. Pathol., 181, 1895, 10.1016/j.ajpath.2012.08.044

Li, 2018, Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3beta signal pathway, Cell Death Dis., 9, 888, 10.1038/s41419-018-0882-5

Zhang, 2017, Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway, Biomed. Pharmacother., 96, 884, 10.1016/j.biopha.2017.10.056

Li, 2015, Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma, Cancer Res., 75, 3181, 10.1158/0008-5472.CAN-14-3721

Gouirand, 2018, Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming, Front. Oncol., 8, 117, 10.3389/fonc.2018.00117

Bandiera, 2015, miR-122--a key factor and therapeutic target in liver disease, J. Hepatol., 62, 448, 10.1016/j.jhep.2014.10.004

Liu, A.M., Xu, Z., Shek, F.H., Wong, K.F., Lee, N.P., Poon, R.T., Chen, J., and Luk, J.M. (2014). miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. PLoS ONE, 9.

Shin, 2017, Precision medicine: The foundation of future cancer therapeutics, NPJ Precis. Oncol., 1, 12, 10.1038/s41698-017-0016-z

Weber, 2010, The microRNA spectrum in 12 body fluids, Clin. Chem., 56, 1733, 10.1373/clinchem.2010.147405

Wu, 2017, lncRNAs: From Basic Research to Medical Application, Int. J. Biol. Sci., 13, 295, 10.7150/ijbs.16968

Nguyen, 2016, Expression Specificity of Disease-Associated lncRNAs: Toward Personalized Medicine, Curr. Top. Microbiol. Immunol., 394, 237

Prabhakar, 2017, Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases, Yale J. Biol. Med., 90, 73

Li, 2017, Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway, J. Cell. Biochem., 118, 4498, 10.1002/jcb.26107

Amodio, 2018, Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity, Leukemia, 32, 1948, 10.1038/s41375-018-0067-3

Ozes, 2017, Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer, Sci. Rep., 7, 894, 10.1038/s41598-017-00966-3

Thông tin
Thông tin xuất bản

International Journal of Molecular Sciences

Tập 19 Số 12

3742

Thông tin tác giả